急性卒中超急性期救护车强化降压试验(INTERACT4):一项随机对照试验的研究方案
INTERACT4是一项在中国50余家中心开展的多中心、前瞻性、随机、开放标签、盲法终点评估(PROBE)试验,计划纳入3116例疑似急性卒中的高血压患者,随机接受救护车强化降压(30分钟内收缩压目标<140 mmHg)或按当地指南的常规血压管理,主要结局为90天改良Rankin量表功能结局。
要点
- 疑似急性卒中高血压患者随机接受救护车强化降压(30分钟内收缩压<140 mmHg)或指南推荐血压管理。
- 主要结局为90天改良Rankin量表7分类有序功能结局。
- 样本量3116例,检验效能90%(α=0.05),以有序logistic回归检测功能结局更差的比值降低22%。
核心结论
- INTERACT4是一项实用性临床试验,旨在为疑似急性卒中患者救护车超急性期降压的有效性和安全性提供可靠证据。
研究设计与样本
- 多中心、救护车给药、前瞻性、随机、开放标签、盲法终点评估(PROBE)试验,在中国50余家中心纳入3116例疑似急性卒中的高血压患者。
- 通过手机数字系统随机分为强化降压组(30分钟内收缩压目标<140 mmHg)或按当地方案指南推荐血压管理组。
- 收集院内临床与管理数据及7天结局后,由培训过的盲法评估者在90天进行电话或面对面身体功能与健康相关生活质量评估。
- 主要结局为90天改良Rankin量表身体功能,按7分类有序结局分析。
- 样本量估计提供90%效能(α=0.05),以有序logistic回归检测功能结局更差的比值降低22%。
关键数值与推荐
- 强化降压目标:30分钟内收缩压<140 mmHg。
- 主要结局:90天改良Rankin量表,7分类有序分析。
- 样本量3116例,效能90%(α=0.05),检测功能结局更差比值降低22%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Early pre-hospital initiation of blood pressure (BP) lowering could improve outcomes for patients with acute stroke, by reducing hematoma expansion in intracerebral hemorrhage (ICH), and time to reperfusion treatment and risk of intracranial hemorrhage in ischemic stroke (IS). We present the design of the fourth INTEnsive ambulance-delivered blood pressure Reduction in hyper-ACute stroke Trial (INTERACT4). METHODS: A multi-center, ambulance-delivered, prospective, randomized, open-label, blinded endpoint (PROBE) assessed trial of pre-hospital BP lowering in 3116 hypertensive patients with suspected acute stroke at 50+ sites in China. Patients are randomized through a mobile phone digital system to intensive BP lowering to a target systolic BP of < 140 mmHg within 30 min, or guideline-recommended BP management according to local protocols. After the collection of in-hospital clinical and management data and 7-day outcomes, trained blinded assessors conduct telephone or face-to-face assessments of physical function and health-related quality of life in participants at 90 days. The primary outcome is the physical function on the modified Rankin scale at 90 days, analyzed as an ordinal outcome with 7 categories. The sample size was estimated to provide 90% power (α = 0.05) to detect a 22% reduction in the odds of a worse functional outcome using ordinal logistic regression. DISCUSSION: INTERACT4 is a pragmatic clinical trial to provide reliable evidence on the effectiveness and safety of ambulance-delivered hyperacute BP lowering in patients with suspected acute stroke. TRIAL REGISTRATION: ClinicalTrials.gov NCT03790800. Registered on 2 January 2019; Chinese Trial Registry ChiCTR1900020534. Registered on 7 January 2019. All items can be found in this protocol paper.
引用
- Song L, Chen C, Chen X, et al. INTEnsive ambulance-delivered blood pressure Reduction in hyper-ACute stroke Trial (INTERACT4): study protocol for a randomized controlled trial. Trials. 2021. PMID: 34872617. doi:10.1186/s13063-021-05860-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。